Medigen shares COVID vaccine tech with WHO in world first
The Taiwanese biotech firm is the first private pharma company to share IP and know-how via a WHO pool set up in 2020
Stay updated with breaking news from Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Taiwanese biotech firm is the first private pharma company to share IP and know-how via a WHO pool set up in 2020
Bringing Taiwan to the World and the World to Taiwan
The COVID-19 Technology Access Pool (C-TAP) has recently announced three new license agreements purchased through the Medicines Patent Pool (MPP). These
The COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual property (IP), knowledge and innovations has announced three new licensing agreements acquired through the Medicines Patent Pool (MPP).
The partnership, called the COVID-19 Technology Access Pool (C-TAP), was launched in 2020, to facilitate timely, equitable and affordable access to COVID-19 health products through public health oriented, transparent and non-exclusive licensing agreements.